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Abstract 
The availability of “omics” technologies is transforming scientific approaches to 
physiological problems from a reductionist viewpoint to that of a holistic viewpoint. This 
is of profound importance in nutrition since the integration of multiple systems at the 
level of gene expression on the synthetic side through to metabolic enzyme activity on 
the degradative side, combine to govern nutrient availability to tissues. Protein activity is 
central to the process of nutrition from the initial absorption of nutrients via uptake 
carriers in the gut, through to distribution and transport in the blood, metabolism by 
degradative enzymes in tissues and excretion through renal tubule exchange proteins. 
Therefore, the global profiling of the proteome, defined as the entire protein complement 
of the genome expressed in a particular cell or organ, or in plasma or serum at a particular 
time, offers the potential for identification of important biomarkers of nutritional state 
that respond to alterations in diet.  This review considers the published evidence of 
nutritional modulation of the proteome in vivo which has expanded exponentially over 
the last three years. It highlights some of the challenges faced by researchers using 
proteomic approaches to understand the interactions of diet with genomic and metabolic-
phenotypic variables in normal populations.
1. Introduction 
 
Technologies have advanced significantly in the past five years to enable us to ask 
holistic questions such as “what proteins/pathways does glucose modulate (e.g. through 
post-translational modification, altered compartmentalization or expression/degradation) 
in islet cells?” rather than the traditional reductionist approach to address an hypothesis in 
a selected target tissue. Embracing this paradigm shift, the open-ended approach to 
investigating mechanisms of physiological effects, can lead to identification of novel 
regulatory pathways possibly leading to new roadmaps for research. The value of 
findings derived from “fishing” approaches is subsequently validated using conventional 
biochemical, cellular and molecular biological approaches both in vitro and in vivo. 
Thus, scientific rigour is maintained and novel mechanistic influences on physiology can 
be identified. 
The systems biology approach offers significant strengths to the field of nutrition, where 
the influence of both genotype/phenotype and external influences have marked effects on 
absorption, distribution, metabolism and excretion and therefore the nourishment of an 
individual organism. Whilst systems biology integrates the temporal study of the 
transcriptome (all mRNA molecules (or transcripts) in one cell or tissue), the proteome 
(total protein complement of a genome present in cells and/or tissue at a given time) and 
the metabolome (entire complement of all the small molecular weight metabolites inside 
a cell suspension or organism), there can be little correlation between these approaches – 
not all changes in mRNA expression are translated directly to changes in protein levels. 
The correlation coefficient in a controlled experimental unicellular environment rarely 
exceeds 0.5 and many changes in protein levels can be attributed to changes in mRNA 
stability; mRNA is around for a longer or shorter period of time prior to degradation and 
therefore is more or less likely to be translated to protein. Similarly, an expressed protein 
is not necessarily an activated protein and therefore may not contribute to the 
metabolome. Such verification is an important qualifier for emergent findings from 
systems biology studies. 
Whilst recognising the need for experimental confirmation of any change in protein level 
on functional effect, the application of proteomics can be easily rationalized in nutrition 
research; proteins are ultimately responsible for absorption and distribution of nutrients 
(glucose and amino acid transporters, apolipoproteins), metabolism (proteases, lipases, 
glycolytic enzymes) and excretion (renal transporters). At the time of preparing this 
article, over the past five years, a PubMed search using the MeSH terms nutrition AND 
proteomics revealed thirty one published review articles. Of note, these articles focused 
on the potential for a revolution in our understanding of nutrition through application of 
proteomic techniques, and, as is often the case for emergent technologies, exceeds the 
total number of studies currently published which have used proteomics to analyse 
nutritional effects in vivo. In order to consider the likely future value of proteomics in 
nutrition research, this review has three objectives; (1) to summarise current 
methodological approaches; (2) to highlight the application of proteomics to the study of 
nutrition in vivo and (3) to consider any possible limitations which may currently hold 
back widespread application of proteomics and the future of proteomics in nutrition 
research.  
 
2. Current methodological approaches  
The publication of the human genome led to the realization that many of the mechanisms 
underlying disease and influencing physiology, are expressed at the supra-genomic level, 
and this had a catalytic effect on development of proteomic methods. Since the 1970s, the 
traditional workhorse of high resolution protein separation has been 2 dimensional 
electrophoresis (2DE) (Anderson & Anderson 1996). However, it wasn‟t until the late 
1990s that this tool was widely applied. This revolution was caused by advances in mass 
spectrometry, particularly in easy to use mass spectrometric techniques that became 
readily accessible to life scientists. More recently, other technologies have been 
developed which offer increased speed through a more simplistic approach. What follows 
is a brief overview of proteomic technologies. For more detailed consideration of the 
methods and their applications, the reader is referred to Aldred et al.(2004).  
All the technologies used in proteomics are held to ransom by pre-analytical variation 
incurred in sample collection, handling and storage, particularly of clinical samples 
where there may be a considerable amount of time between collection and analysis. 
Nevertheless, a recent study demonstrates that length of time to freezing (up to 24h) did 
not significantly affect SELDI-TOF MS variability in blood or urine (Traum et al. 2006). 
 
2.1 Sample preparation 
For all proteomic techniques good sample preparation is the key to success. The 
composition of any particular sample will differ according to source, however, most 
samples will encounter problems associated with the simultaneous presence of highly 
abundant proteins and low copy number proteins causing a sensitivity problem over the 
wide dynamic range in protein quantitation. If plasma is used as an example, the dynamic 
range in protein concentration is around six orders of magnitude. The most abundant 
protein, albumin, and the following nine most abundant proteins make up nearly 70% of 
the plasma protein composition. Thus, any scarce proteins are masked, hard to find and 
difficult to observe changes in expression or modification. A compounding feature of the 
plasma matrix is that the low abundance proteins are also possibly the most interesting; 
tissue exudates, cytokines and growth factors may all lie hidden. Therefore, the first step 
in sample preparation can be their simplification by lowering the complexity of the 
sample; this can be achieved wither by removing interfering substances or enriching in 
certain species of interest (Righetti et al. 2005). For example, high abundance proteins 
like albumin and globulins can be removed by immunoprecipitation techniques, although 
it should be noted that whilst removing high abundance proteins, other associated 
proteins may also be extracted, highlighting the need for verification of findings using 
non-manipulated samples. Alternatively, specific pools of proteins can be analyzed. 
These include; proteins with a particular post translational modification such as 
phosphorylation which can be immunoprecipitated (Kabuyama et al. 2004); proteins in 
particular sub-cellular locations such as the mitochondrion which can be enriched using 
ultracentrifugation techniques (Warnock et al. 2004); or newly transcribed proteins which 
can be metabolically labeled.  
 
2.2 Gel based technologies 
The most widely used of the gel based proteomic technologies is 2-dimensional gel 
electrophoresis (2DE) utilizing iso-electric focusing and SDS-PAGE, where proteins are 
separated by charge in the first dimension and mass in the second. The technological 
advancement in iso-electric focusing has enabled single pI unit range immobilized pH 
gradient (IPG) strips, zoom strips, which allow for very high resolution separations. 
Following 2DE, each gel comprises a series of spots where each spot corresponds to one 
or more protein species. Alternatively, a subset of proteins can be isolated by using 
Western blotting for post-translational modifications to further limit the number of 
proteins taken through to analysis. Quantitative protein expression profiling is achieved 
by visualizing gels post-staining with one of a variety of chromophores such as 
Coomassie Blue or silver (both of which have a limited dynamic range), and more 
recently fluorescent dyes such as the Sypro family have improved the sensitivity and 
dynamic ranges.  
The fluorescent cyanine dyes (Cy2, Cy3 and Cy5) which carry n-hydroxysuccinimidyl 
ester functionality and bind the -amino group on lysine residues, have also been 
introduced to 2DE. This allows the labeling of three spectrally resolvable fluorophores 
and enables the simultaneous visualization of test, control and standard gels (Kolkman et 
al, 2005). The difference in gel electrophoresis (DIGE) approach has been validated for 
use in quantitative proteomics although cost precludes its routine application.  
Once visualized, the gels images are captured and in silico representations are analyzed 
by a variety of algorithms and software options. Proteins of interest, once identified, are 
then excised from the gel or membrane and subjected to limited trypsinisation. The 
resulting peptides are extracted and identified using either Matrix Assisted Laser 
Desorption Ionization Time Of Flight Mass Spectrometry (MALDI-TOF MS) or tandem 
MS techniques (see Section 2.5). Another emerging technology is the application of 
column separation by capillary electrophoresis (Fliser et al. 2005), which has the 
advantage of being able to cope with crude samples with high salt concentration such as 
urine. Peak picking algorithms are used to differentiate the peptide between control and 
test prior to sample identification by MS. 
 
2.3 Chromatography based technologies 
Chromatographic methods based on different matrices have been used to separate 
proteins for over 50 years. For many proteomic applications proteins in a sample are first 
digested to peptides and then these are separated chromatographically prior to mass 
spectral protein identification. The simplest methods merely slow down the rate at which 
the peptides enter the analyzer so that the maximum amount of time can be taken to 
identify as many of the peptides as possible, so called shotgun proteomics. Multi 
dimensional chromatography techniques, such as MudPIT which uses columns consisting 
of strong cation exchange material back-to-back with reversed phase material separate 
peptides prior to elution and ionization within the mass spectrometer, in much the same 
manner (Wolters et al. 2001). However, many techniques are used to extract or highlight 
peptides of choice. For example, Immobilized Metal ion Affinity Chromatography 
(IMAC) utilizes chromatographic media with bound nickel ions to extract 
phosphopeptides from complex mixtures, thus enabling the identification of peptides 
from proteins involved in signaling cascades (Riggs et al. 2001). Isotope-Coded Affinity 
Tags (ICAT) methodologies use stable isotope tags to differentially label two samples 
which can then be mixed. The mixture is then chromatographically separated and 
quantitatively identified by mass spectrometry (Gygi et al. 1999). The most commonly 
used tags bind to cysteine residues in the proteins, thus fewer peptides are labeled. Stable 
isotope labeling with amino acids in cell culture (SILAC) (Ong et al. 2002), a 
complementary technique to ICAT, labels the proteins with light or heavy carbon (
12
C or 
13
C) or nitrogen (
14
N or 
15
N) usually incorporated into the samples during growth in 
medium containing labeled lysine. The resulting processed samples are then analyzed by 
mass spectrometry and give quantitative answers as with ICAT. However, this does 
require the synthesis of new proteins and thus is only of use in cell culture work or in fast 
growing organisms as its name suggests.  
 
2.4 Protein arrays 
The success of gene arrays for transcriptomics has lead to the idea of protein arrays. 
However, with nothing analogous to PCR for the amplification of signal and the lack of a 
single complimentary hybridization substrate, the development of the technology has 
proven to be more difficult. Different interacting molecules such as antibodies, DNA and 
drug molecules have been used as bait to identify components of protein samples. Once 
the proteins have bound to the bait they must then by identified and quantitated, requiring 
the application of mass spectrometry (Pavlickova et al. 2004). In fact, this baiting 
approach is a natural development from the basis of Surface Enhanced Laser Desorbtion 
Ionisation (SELDI) time of flight MS (TOF MS) (Issaq et al. 2002). The SELDI approach 
was pioneered by Ciphergen to enable the analysis of complex proteomes such as plasma 
and enables the selective capture of proteins by varying the nature of the capture matrix 
 
2.5 Protein identification 
All of the above techniques are reliant on the successful identification of the protein or 
peptide. The favoured technique for this is mass spectrometry (Yates 2004); (Barrett et al. 
2005). The two most commonly used technologies are matrix assisted laser desorption 
ionization time of flight mass spectrometry (MALDI-TOF MS) and electrospray 
ionization mass spectrometry (ESI MS). The first uses solid state peptides and the latter 
liquid state peptides. MALDI-TOF MS has become the choice for many life scientists 
because of the ease of use and of analysis. Essentially, it produces mass-mapping of an 
unknown single protein derived from a spot on 2DE gel is accomplished by breaking the 
protein into specific peptide fragments using trypsin which cleaves after lysine/arginine 
residues. Mass spectrometric analysis of the enzymatic digest generates a 'mass-map' 
which is unique to the digested protein and allows unambiguous identification of mass 
fingerprints through public databases using the Mascot search engine.  The probability of 
protein identifications being correct is calculated according to the MOWSE score 
(molecular weight search based on peptide scoring frequency) defined by Pappin et 
al.(1993).  
ESI MS lends itself more easily to tandem techniques where peptides can be sequenced 
directly and thus provides greater security to protein identification, over mass 
fingerprinting. Once a protein is identified, it is essential to ensure that the proteins or 
peptides identified are contextually accurate. This can often be achieved by a 
complementary technique such as Western blotting or fluorescence microscopy, where 
the lack of need for sample manipulation should at strength to the observation.   
 
3. Application of proteomics to nutrition 
Whilst the number of articles describing proteomic applications to nutrition has increased 
exponentially since 2002, the majority of these approaches describe single cell models in 
tissue culture. This can provide some important evidence for mechanisms of nutrient 
effect but can provide limited information on systems interactions. For that reason, the 
following section is limited to a review of those studies undertaken in vivo, both in 
human and in animal models.  Application of the in vivo limit to PubMed searches led to 
the recovery of four major experimental themes; those investigating the pathophysiology 
of dietary deficiency states; those investigating the mechanisms by which  nutrients may 
modify disease states; those evaluating the effects of supplementation with micro- and 
macro-nutrients and excess of particular nutrients on otherwise normal subjects/animals. 
In many respects it is too early to consider concordance between nutrition-proteomic 
studies as no two studies are the same, however, these articles are considered in a 
systematic way below and attention is paid to whether the articles have verified their 
findings using alternative experimental approaches. 
 
3.1 Use of proteomics to investigate mechanisms underlying pathophysiology of 
nutritional deficiency states 
 
For ethical reasons, the study of experimentally induced nutritional deficiency states is 
undertaken in animal models, however, in addition to understanding the multiplicity of 
pathophysiological states, one of the possible outcomes of such studies is the 
identification of possible early biomarkers of functional deficiency which may be applied 
to vulnerable populations (Go et al. 2005). 
The consequences of prolonged K
+
 deficiency on the mouse renal proteome have been 
investigated by Thongboonkerd et al.(2006) as hypokalemia is known to be associated 
with a number of complications including metabolic alkalosis, polyuria and renal tubule 
injury. These workers applied 2DE differential analysis of the kidney proteomes from 
normal or dietary depleted mice (8 weeks) and reported 33 differentially expressed 
proteins in the kidney proteome of K-deficient mice. Using MS based approached 30 of 
these proteins were identified and fell into three major protein function classes; metabolic 
enzymes, signalling proteins and cytoskeletal proteins. Some of the metabolic enzymes 
identified are involved in metabolic alkalosis and thus warrant further study as putative 
effectors of K
+
 deficiency. 
A consideration of the sub-clinical effects of copper and iron deficiency has been recently 
reported by Tosco et al.(2005). These metals are important cofactors for a number of 
enzymes involved in normal physiological processes and their deficiency has widespread 
consequences in brain development and vascular function (Schuschke DA, 1997; 
Prohaska, 2000). Differential analysis of the rat intestinal proteome showed significant 
changes in the expression of proteins associated with glucose and fatty acid metabolism, 
molecular chaperones, cytoskeleton and vitamin transporters.  Again, this work highlights 
novel pathways for considering the consequence of unbalanced micronutrient intake, with 
alterations to the cytoskeletal proteome being modified in both studies. 
Chanson et al. (2005) investigated the effects of folate deficiency on the rat liver 
proteome as low liver folate has been shown to increase abnormal one-carbon 
metabolism and the risk of degenerative disease. Young rats were fed an amino acid-
defined, folate deficient diet for four weeks and compared to animals receiving a normal 
diet. Again, a 2DE approach was adopted and differentially expressed proteins were 
determined by MALDI-MS. These workers identified 5 up-regulated proteins and four 
down-regulated proteins in folate deficient rats; the up-regulated proteins included 
glutathione peroxidase and peroxiredoxins which are indicative of an increased level of 
hepatic oxidative stress (Cessarato et al. 2005). Importantly, these researchers confirmed 
the observation that glutathione peroxidase levels are upregulated in the liver of folate 
deficient animals using a Western blotting approach. 
   
3.2 Using proteomics to investigate mechanisms of disease process using nutrients 
and micronutrients 
 
Certain micronutrients, including selenium and tocopherol, have been suggested to have a 
chemopreventive effect in prostate cancer (Rayman, 2005). To investigate the potential 
for defining a disease phenotype which may be modified by micronutrient 
supplementation, Kim et al. (2005) have studied the plasma proteome of controls and 
prostate cancer patients after dietary supplementation with  vitamin E, selenium, both or 
placebo for 3-6 weeks. Pre-fractionation of plasma to examine the lower MW (2-
13.5kDa) proteins by using SELDI-MS was adopted as the method of choice and using 
principal component analysis, these workers were able to differentiate a prostate cancer 
plasma proteome from the matched control. Moreover, they showed that the combination 
of selenium and vitamin E induced significant changes in the cancer patients‟ proteomes 
towards a profile indicative of prostate-cancer free status. Identification of a disease 
versus normal protein profile provides an approach which can be used to monitor 
therapeutic responsiveness without any need for identification of the proteins involved.  
A similar approach, using proteomics to identify specific multi-protein profiles associated 
with pathology which may not be evident from conventional methods, has been 
undertaken by Weissinger at al. (2006).  These workers adopted a shotgun proteomics 
approach to investigate effects of oral vitamin C supplementation in hemodialysis 
patients. They were able to define a plasma polypeptide fingerprint comprising 30 
different species that characterized patients with renal dysfunction undergoing 
hemodialysis and furthermore, were able to show that several of the polypeptides were 
normalised following supplementation with vitamin C (250mg/d) for three weeks. Whilst 
definition of these polypeptides is of interest to provide insight into the functions of 
vitamin C in haemodialysis patients, it is not necessary to know their identity, only their 
m/z signal, to follow response to diet/treatment.     
Using a mouse model of mammary cancer (with dimethylbenz[a]anthracene as the tumor 
promoter), Rowell et al. (2005) adopted a conventional proteomic approach based on 
2DE and MALDI-TOF analysis to define a novel mechanism of chemoprotection 
afforded by the soy isoflavone, genestein. Whilst six proteins appeared to be altered by 
pre-pubertal exposure to genistein but not daidzein (500g/g), five were further 
investigated and up-regulation of only one, GTP-cyclohydrolase-1, was confirmed by 
Western blotting. To pursue the importance of this finding further, the authors considered 
the downstream signalling from GTP-CH1 and were able to confirm that tyrosine 
hydroxylase was upregulated whereas VEGF2R was downregulated in rats at 50 days, 
when administered with genistein in the pre-pubertal period. Thus, a proteomic approach 
allowed the postulation of a novel mechanism for the chemoprotective effects of 
genistein through inhibition of angiogenesis.        
A similar approach was adopted by Poon et al. (2005) to further investigate the 
observation that -lipoic acid can reverse memory impairment in the senescence 
accelerated prone mouse (strain 8; SAMP8). Using 2DE separation with LC-MS/MS to 
define proteins with altered expression profiles, these authors reported that lipoic acid 
supplementation was able to prevent the development of accelerated ageing phenotype. 
Specifically, they observed restoration of expression of neurofilament triplet L protein, 
enolase and ubiquitous mitochondrial creatinine kinase to levels seen in normal mice 
and prevention of the oxidation of lactate dehydrogenase B, dehydropyrimidinase-like 
protein 2 and -enolase in mice receiving -lipoic acid, however, further functional 
studies or application of other techniques to confirm findings are not described in this 
article.  
There are many studies suggesting that dietary fatty acids particularly fish oils may have 
a significant effect on atherosclerosis, but a recent meta-analysis has not supported this 
funding (Hooper et al. 2006). Given this disparity in the literature, further evaluation of 
the effects of such fatty acids on vascular function is warranted. In this regard, in the 
medium term, proteomics may offer some insight into the variable outcomes of 
intervention studies. In the short term, investigation of the effects of dietary fatty acids in 
animal models, specifically effects of fish oil, cis9, trans11- and trans10, cis12-
conjugated linoleic acid or elaidic acid on the liver proteomes of mice with 
hypercholesterolaemia due to apoE deletion or expression of the apoE* Leiden transgenic 
mice (de Roos et al. 2005a, 2005b) may also provide some clues. The first study (de 
Roos, 2005a) used a conventional 2DE approach to examine differential protein 
expression and principal component analysis to determine which proteins were sensitive 
to the effects of fish oil. This investigation showed that fish oil had a major effect on 
cytosolic proteins but that the effects of elaidic acid were restricted to membrane 
proteins. In addition, the authors were able to correlate physiological effects on plasma 
insulin, glucose, cholesterol and fatty acid levels with proteomic changes; a change was 
observed in levels of the  proteins, long-chain acyl-CoA thioester hydrolase and 
adipophilin, which contributed to the induction of a phenotype consistent with metabolic 
syndrome after dietary enrichment with  conjugated linoleic acid. The more recent study 
focused on supplementing with dietary conjugated linoleic acids (CLA) in ApoE 
knockout mice (de Roos et al. 2005b); the principal defining protein expression change 
following cis9, trans11 CLA administration was the upregulation of hsp70 family 
members. The differential effect of trans10, cis12 CLA was confirmed by principal 
component analysis; the key enzymes upregulated were enzymes associated with 
gluconeogenic, beta oxidation and ketogenic pathways. In this model, increased levels of 
hepatic serotransferrin, an acute phase reactant, were associated with a phenotype of 
insulin resistance, thus making a tantalizing link between the metabolic syndrome and 
inflammation which merits further study. 
 
3.3 Effects of dietary supplementation/enrichment on the proteomes of healthy 
organisms 
The studies described above give some indication that disease activity or outcome may be 
modulated by nutritional means, however, in the mammary cancer model, dietary 
intervention was required prior to induction of the cancer. Similarly, vascular occlusion 
in subjects presenting with clinical manifestations of disease is likely to have developed 
over three decades or more and the potential for dietary supplements to reverse such 
changes seems remote. As epidemiological evidence is in support of a beneficial effect 
for many micronutrients on health outcomes this may be due to early intervention before 
disease can become established, thus the advancements offered by proteomic 
technologies may facilitate an understanding of preventative mechanisms in healthy 
subjects. The following five articles detail proteomic investigations of nutrient effect in 
normal subjects/animals. 
Our recent paper (Aldred et al. 2006) describes the use of 2DE with MALDI-MS to 
investigate the plasma proteome response to increasing doses of alpha-tocopherol over 
four weeks. Subsequent analysis of the pooled 2DE proteomes led to the identification of 
increased expression of proapolipoprotein A1 following tocopherol supplementation, 
with time and dose-dependent effects. This was confirmed in each individual non-
manipulated plasma sample to ascertain that the effect was not due to albumin depletion 
or due to pooling. Importantly, this work demonstrated a novel mechanism of benefit in 
healthy subjects, that tocopherol may increase hepatic synthesis of ApoA1 which is 
involved in reverse cholesterol transport and is inversely related to cardiovascular disease 
risk. 
The effects supplementation of the diet with cruciform vegetables on the serum proteome 
of healthy subject was reported recently by Mitchell et al. (2005). These workers applied 
MALDI-TOF MS to serum samples depleted of major proteins such as albumin, and 
applied logistic regression models and peak picking algorithms to distinguish participants 
who had followed a 7 day diet with cruciform vegetables from those following a 7 day 
diet without the vegetables. The technique proved powerful enough to classify the 
participants‟ diets to 76% accuracy using two m/z peaks; one of these peaks was 
subsequently identified as the B-chain of alpha 2-HS glycoprotein, a serum protein 
previously found to be involved in insulin resistance (Dahlman et al. 2004). 
There is increasing evidence for the benefits of anthocyanadins against cognitive decline, 
although the mechanisms underlying these effects are unknown (Galli et al. 2002). To 
investigate this further, Kim et al. (2006) have undertaken a proteomic investigation into 
the potential physiological benefits of six weeks of grape-derived dietary supplements 
(GSE) on the whole rat brain. Using a 2DE approach and peptide mass fingerprinting by 
MALDI-MS, thirteen proteins were determined to be different in the brains of animals 
exposed to GSE compared to control brains. These included proteins associated with 
energy generation, such as creatine kinase, heat shock proteins and cytoskeletal proteins 
including neurofilament protein light chain; the latter was described by Poon et al. (2005) 
as being restored in the brains of accelerated ageing mice following administration of 
lipoic acid, again supporting the hypothesis that neurofilament protein may have an 
important role in preventing cognitive decline.  
The final studies which meet the criteria for inclusion as proteomic studies detailing the 
effects of nutrients on normal organisms, describe different objectives; to evaluate 
whether diet improves meat quality through reducing oxidative degradation of muscle 
proteins or improves growth rate. The first of these by Stagsted et al. (2004) used a 
proteomic approach to separate chicken muscle proteins together with an immunoblotting 
approach to detect oxidation as protein carbonyls or nitrotyrosine. In common with the 
earlier report of Poon et al. (2005), alpha-enolase was found to be highly susceptible to 
oxidation and in this study, the levels of oxidation of enolase in chicken muscle were 
reduced in chickens fed a diet supplemented with antioxidant-rich fruit and vegetables 
compared with those animals receiving a low-antioxidant diet. 
The second related study, undertaken by Martin et al. (2003) in rainbow trout, aimed to 
determine whether substitution of fish meal for soy meal had an effect on growth and if 
so, to discover the mechanism using a proteomic approach. Using a 2DE approach with 
MALDI-TOF MS for peptide mass mapping, thirty three peptides were differentially 
expressed between control and soy fed animals but no difference in growth rate was 
reported between the diets. The change in expression of transcripts for two proteins, 
apolipoprotein A1 and aldolase B confirmed the proteomic findings and suggested that 
fish fed the soy diet were exhibiting increased metabolism of proteins and cholesterol. In 
support of our work in healthy humans (Aldred et al. 2006) apolipoprotein A1 expression 
has again been shown to be sensitive to dietary nutrients. 
These latter two studies demonstrate the potential for commercial gain through 
application of proteomics to study mechanism of improved productivity. 
 
3.4 Effects of dietary excess on the proteomes of otherwise healthy organisms 
Whilst there are also reports in the literature which have adopted a proteomic approach to 
describe the effects of nutrient excess on physiology, they are beyond the scope of this 
review. The findings from these works are summarized in Table 1 and the reader is 
referred to the original publications for further information. 
Table 1 – Key features of extracted data from proteomic studies of “over-nutrition” 
Nutrient Species Tissue 
examined 
Key observation Reference 
Cholesterol Mouse Liver Show testosterone deficiency 
(phenotype); expression of 
androgen regulated proteins 
carbonic anhydrase III and 
glutathione s-transferase P2 
also reduced. 
Feng et al 
(2005) 
Cholesterol Mouse Blood vessels Cys peroxiredoxin was 
oxidized and correlated with 
extent of lesion formation 
Mayr et al 
(2005) 
Fat Mouse Gastrocnemius 
muscle, white 
and brown 
adipose tissue 
and liver 
Brown adipose tissue 
increased expression of 
tricarboxylic acid cycle 
enzymes and respiratory chain 
proteins suggesting increased 
energy expenditure to defend 
against weight gain 
Schmid et 
al (2005) 
copper Sheep liver Increase in cytosolic isocitrate 
dehydrogenase, mitochondrial 
thioredoxin-dependent 
peroxidase reductase and 
cathepsin D in liver which 
associated with acute 
mitochondrial damage.  
Haywood et 
al (2005) 
 
  
Many of the articles reviewed above, have focused on the potential for nutrients to 
increase protein expression. However, the steady state level of a particular protein species 
is the summation of both synthetic and degradative changes. There is little data available 
yet on how nutrients may regulate turnover, however, a proteomic approach has led to the 
postulate that post-translational modification of proteins by o-GlcNAc may occur when 
cellular glucose concentrations rise and this may inhibit proteasomal degradation of 
transcription factors and therefore allow cells to regulate transcriptional activity 
according to nutritional status (Zachara and Hart, 2004); when they have an energy 
source, they can transcribe proteins and in the absence of glucose, proteasomal 
degradation of transcription factors is enabled. 
 
4. Current Limitations  
Whilst these studies are beginning to demonstrate the value of proteomics, any 
summation of data can only be considered valid if there is confidence in the analytical 
methodology per se. Several important caveats remain and require closer inspection; 
 How recoverable is the cellular or plasma proteome? 
 How accurate are the quantitative proteomic techniques? 
 What is the likelihood of statistical anomaly/false positives through multiple 
sampling error?  
The current approaches to solving these methodological issues are described below and 
will allow the power of proteomics to be confidently accepted and potential benefits for 
nutrition research to be recognised. 
 
4.1 How recoverable is the cellular or plasma proteome? 
As alluded to earlier in the review, solubility problems can limit representation of highly 
hydrophobic membrane proteins which are difficult to recover using commonly available 
detergents. New detergents are being developed to extend the application of proteomics 
to low solubility proteins (Stanley et al. 2003; Rabilloud et al. 2003), in particular in the 
development of zwitterionic detergents such as C7BzO. However, there is no universal 
method for extracting different membrane proteins and individual optimization is 
necessary using a panel of detergents. 
A different challenge faces those studying the plasma proteome, namely the wide 
dynamic range of protein components which is in the order of 10
12
. Lower abundance 
proteins are masked by high abundance proteins such as albumin and immunoglobulins, 
as previously described in section 2.1. Albumin can be “selectively” removed using 
chemical (cibacron blue) or antibody techniques, however, albumin is tightly associated 
with many small peptides in plasma and removal of albumin is also likely to deplete 
hormones including thyroid and steroid hormones. Initial fractionation using strong 
detergents prior to removal of high abundance proteins offers a more secure route for 
analyzing low abundance proteins without the problems of inadvertent peptide depletion, 
however, detergent denaturation also destroys the properties that allow certain 
components to be depleted. The recent HUPO Plasma Proteome Project report (Omenn et 
al, 2005) has highlighted the key issues to be addressed over the next few years to 
improve the value of data which can be derived from plasma samples. 
The SELDI TOF – MS approach has been applied to several of the studies reviewed in 
this article, however, it preferentially detects low MW peptides as they have a higher 
efficiency of ionization. This technology also poses some challenges in protein 
identification which is based on peptide mass matching of complex mixtures and can not 
inherently accommodate post-translational modifications; the lack of identity of the 
putative biomarkers remains unaddressed. Overall, SELDI has been suggested to suffer 
with high noise levels, and from low sensitivity and specificity (Diamandis, 2004). 
Indeed, protein concentrations responsible for the „peaks‟ in SELDI are normally in the 
µg/ml range, much higher than many known biomarkers for cancer. The plasma 
proteome HUPO report (Rai et al, 2005) has recommended stringent standardization and 
pre-fractionation to increase the utility of the SELDI approach after intra-laboratory CVs 
revealed variations from 15 to 43% across five laboratories. 
 
4.2 How accurate are the quantitative proteomic techniques? 
Stable isotope labeling (ICAT) has been a core technology for use in quantitative 
proteomic mass spectrometry, however, there can be some issues with variability due to 
incomplete labeling and the need for such experiments to be conducted in the presence of 
isotopes. Recent attention has focused on peptide peak area quantification and this 
technology has been successfully applied to characterization of the proteomes of wild-
type and p53 deficient HCT-116 human cells with acceptable reproducibility (Xie et al, 
2006). Comparison of ion peak areas following analysis by ion trap or Fourier transform 
MS provided CVs in the order of 10%. However, such an analysis will normally follow 
on from the identification of spots by 2DE which differ at least two-fold and this stage 
alone can introduce errors in spot identification through differences in sample loading 
between gels, gel to gel warping and variation during fixation. Whilst complex 
algorithms exist in 2DE analytical software packages to maximize intelligent matching, 
this is usually overseen by an experienced operator and as such presents a huge bottle-
neck in comparative proteomics. For this reason, the development of DIGE has afforded 
significant benefits; whilst expensive to use routinely, it offers the potential to directly 
compare two samples within the same gel. As with all 2DE analysis, some spots may not 
be detected by DIGE if their isoelectric points or molecular weights lie outside the range 
of the IPG strips. Such a problem is not encountered in direct mass spectrometry 
techniques.  
In a recent study designed to examine the consistency between DIGE and ICAT, there 
was limited overlap between detected proteins suggesting that such techniques should be 
regarded as complementary rather than alternative methods of analysis (Wu et al. 2006). 
 
4.3 Size of effect and sample size in proteomics 
From the earlier discussion, it is evident that the combination of experimental variation 
and intrinsic complexity of mixed protein samples contributes to the background “noise” 
in proteomics. This so called “high dimensionality” of the data, due to the equivalent or 
smaller number of samples being analysed compared with the number of data points or 
protein spots being detected, increases the risk of “overfitting” the data. To overcome this 
problem and minimize risk of identifying false positives, machine learning techniques 
have been developed to reduce the dimension of putative biomarker proteins and yield a 
manageable set of proteins for further validation. A recent report has described the 
application of support-vector machine learning techniques to simulated data sets to 
demonstrate the robustness against identification of outliers and subsequently to real 
SELDI data sets from a breast cancer proteomics study (Zhang et al, 2006); biomarkers 
“identified” by the algorithm were subsequently validated in biological experiments, for 
example a peptide which was sequenced by direct on chip sequencing technique was 
followed up breast cancer patients and found to associate with disease status. 
 In addition to complexity in the technology which creates “high dimensional” data sets, 
the genetic variability in human studies adds further complications to the application of 
proteomics to nutritional intervention studies in humans. One of the key issues in 
considering nutrition in healthy subjects is that homeostatic mechanisms which serve to 
maintain normal physiology are by definition, likely to reduce any effects of diet on the 
proteome. This is less of a problem in animal studies using in-bred species. However, in a 
cohort of human subjects recruited to a nutritional intervention study, inter-individual 
variability due to genotypic differences in any given proteome is likely to exceed the 
changes induced by environment or diet. In our recent study of the plasma proteome 
following alpha-tocopherol supplementation (Aldred et al, 2006), with ten or eleven 
subjects in each of three supplementation groups measured at baseline, after two weeks 
and after four weeks, the evidence suggested that inter-individual variation in protein 
expression exceeded that of the supplement. In order to circumvent these issues, samples 
from subjects in the same supplement group and at the same time point were pooled. 
Such pooling reduces individual noise between subjects but also may lead to the loss of 
individual responsiveness and possible dilution of effect, therefore the need to confirm 
2DE findings using native, individual samples is very important.  
Pooling has also been necessitated in the past when cohort sizes are large; for example, 
an experiment with 12 different paradigms and three replicate gels per experiment or 
population based studies with 50 individuals under two different regimes, also using 
replicate gels, the number of gels becomes costly, and the extent of analysis, unwieldy.  
Current software uses algorithms to match gels, allowing for analysis of protein quantity. 
The proteins of interest can then be found by using Boolean or fold changes. Advances in 
bioinformatics and multiple component analysis to enable analysis of large numbers of 
gel data sets (>100) each with up to 1000 spots per gel, will provide a route to work 
through such inter-individual variability and large sample sizes to define consistent 
patterns of effect without the need for sample pooling. 
 5. Future approaches  
The technology underlying proteomics continues to progress from the most basic level in 
improving dyes which can provide linearity with protein expression over a wide dynamic 
range, to improving software packages to deal with multiple gels and associated 
intelligent systems to analyse data with minimal bias.  Many steps are being taken 
towards miniaturisation both of sample size use and of instruments, because of the 
limited and unique samples which are available from clinical settings, including the 
moves towards lab-on-a-chip scenarios (Diks and Peppelenbosch 2004; Marko-Varga et 
al. 2004). Advances in mass spectrometry are making it possible to do simultaneous 
tissue imaging and profiling, putting biochemical findings into the context of disease 
state. Electron tomography is beginning to produce 3 dimensional maps of cells and 
proteins (Baumeister 2005).  
Further steps beyond proteomics such as temporal and spatial analyses will help build 
systems biology information (Papin and Subramaniam 2004). However 70-80% of the 
proteome still remains to be seen and so new separation techniques, such as (1) 
multistacking chromatography which consists of a set of immobilized chemistries, 
serially connected in a stack format to resolve proteins prior to MS and (2) solid phase 
ligand libraries where a library of combinatorial ligands is coupled to small beads prior to 
mixing with a complex proteome to significantly reduce the concentration differences in 
between proteins such as plasma, need to be adopted to increase visualisation of proteins 
(Righetti et al. 2005). The first steps towards sharing and standardization of proteomic 
and mass spectral data has begun through projects such as MIAPE by the Human 
Proteomics organisation. This will facilitate data comparison between labs and will allow 
the importance of proteomics in nutrition to be fully realised.    
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